Divyansh Agarwal
Prateek Agarwal
Daniel Zhang

Venture Description: 

This year more than 650,000 patients will receive chemotherapy. The vast majority of them will experience a reduction in blood cell counts as a side effect of these drugs, which can lead to serious complications and even death. To solve this problem, we have developed Sanguis, the world's first hand-help, portable and inexpensive blood cell counting device.


Recipient of PennHealthX Ventures Seed Funding
Weiss Tech House Innovation Fund Winner
Wharton Entrepreneurship Fund Winner
Science Center Phase 1 Ventures Winner
PennApps Accelerator Winner
Port Incubator: Spring 2017 Class
Penn I-Corps Winner
Innovation Seed Grant Winner: Big Ideas through Small Technology
Became a member of Philadelphia Alliance for Capital & Technologies
Baylor NVC Elevator Pitch Winner